Haemonetics Corp. (HAE)
108.40
-0.40
(-0.37%)
USD |
NYSE |
Aug 24, 16:00
108.39
-0.01
(-0.01%)
Pre-Market: 20:00
Haemonetics Shareholders Equity (Quarterly) : 837.10M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 837.10M |
| March 31, 2026 | 796.32M |
| December 31, 2025 | 911.45M |
| September 30, 2025 | 849.17M |
| June 30, 2025 | 882.30M |
| March 31, 2025 | 820.84M |
| December 31, 2024 | 906.86M |
| September 30, 2024 | 878.85M |
| June 30, 2024 | 905.37M |
| March 31, 2024 | 959.96M |
| December 31, 2023 | 943.32M |
| September 30, 2023 | 893.66M |
| June 30, 2023 | 864.62M |
| March 31, 2023 | 818.00M |
| December 31, 2022 | 775.98M |
| September 30, 2022 | 729.01M |
| June 30, 2022 | 770.42M |
| March 31, 2022 | 749.42M |
| December 31, 2021 | 730.78M |
| September 30, 2021 | 698.55M |
| June 30, 2021 | 677.08M |
| March 31, 2021 | 731.67M |
| December 31, 2020 | 719.15M |
| September 30, 2020 | 667.92M |
| June 30, 2020 | 608.57M |
| Date | Value |
|---|---|
| March 31, 2020 | 587.11M |
| December 31, 2019 | 574.58M |
| September 30, 2019 | 583.75M |
| June 30, 2019 | 590.97M |
| March 31, 2019 | 667.87M |
| December 31, 2018 | 643.13M |
| September 30, 2018 | 701.34M |
| June 30, 2018 | 674.06M |
| March 31, 2018 | 752.43M |
| December 31, 2017 | 822.81M |
| September 30, 2017 | 801.25M |
| June 30, 2017 | 772.77M |
| March 31, 2017 | 739.61M |
| December 31, 2016 | 770.90M |
| September 30, 2016 | 749.11M |
| June 30, 2016 | 715.56M |
| March 31, 2016 | 721.56M |
| December 31, 2015 | 719.55M |
| September 30, 2015 | 776.88M |
| June 30, 2015 | 791.65M |
| March 31, 2015 | 826.12M |
| December 31, 2014 | 833.91M |
| September 30, 2014 | 820.72M |
| June 30, 2014 | 815.07M |
| March 31, 2014 | 837.89M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp. | 24.93B |
| Integra LifeSciences Holdings Corp. | 1.043B |
| Globus Medical, Inc. | 4.769B |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.365B |
| Total Liabilities (Quarterly) | 1.528B |
| Debt to Equity Ratio | 1.403 |
| Current Ratio | 3.080 |
| Net Debt Paydown Yield | 0.64% |